Global Generic Injectables Market Insights and Forecast to 2028

Report ID: 1242216 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Generic Injectables Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Small Molecule
        1.2.3 Large Molecule
    1.3 Market by Application
        1.3.1 Global Generic Injectables Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Anesthesia
        1.3.4 Anti-Infectives
        1.3.5 Parenteral Nutrition
        1.3.6 Cardiovascular Diseases
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Generic Injectables Market Perspective (2017-2028)
    2.2 Generic Injectables Growth Trends by Region
        2.2.1 Generic Injectables Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Generic Injectables Historic Market Size by Region (2017-2022)
        2.2.3 Generic Injectables Forecasted Market Size by Region (2023-2028)
    2.3 Generic Injectables Market Dynamics
        2.3.1 Generic Injectables Industry Trends
        2.3.2 Generic Injectables Market Drivers
        2.3.3 Generic Injectables Market Challenges
        2.3.4 Generic Injectables Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Generic Injectables Players by Revenue
        3.1.1 Global Top Generic Injectables Players by Revenue (2017-2022)
        3.1.2 Global Generic Injectables Revenue Market Share by Players (2017-2022)
    3.2 Global Generic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Generic Injectables Revenue
    3.4 Global Generic Injectables Market Concentration Ratio
        3.4.1 Global Generic Injectables Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Generic Injectables Revenue in 2021
    3.5 Generic Injectables Key Players Head office and Area Served
    3.6 Key Players Generic Injectables Product Solution and Service
    3.7 Date of Enter into Generic Injectables Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Injectables Breakdown Data by Type
    4.1 Global Generic Injectables Historic Market Size by Type (2017-2022)
    4.2 Global Generic Injectables Forecasted Market Size by Type (2023-2028)
5 Generic Injectables Breakdown Data by Application
    5.1 Global Generic Injectables Historic Market Size by Application (2017-2022)
    5.2 Global Generic Injectables Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Generic Injectables Market Size (2017-2028)
    6.2 North America Generic Injectables Market Size by Type
        6.2.1 North America Generic Injectables Market Size by Type (2017-2022)
        6.2.2 North America Generic Injectables Market Size by Type (2023-2028)
        6.2.3 North America Generic Injectables Market Share by Type (2017-2028)
    6.3 North America Generic Injectables Market Size by Application
        6.3.1 North America Generic Injectables Market Size by Application (2017-2022)
        6.3.2 North America Generic Injectables Market Size by Application (2023-2028)
        6.3.3 North America Generic Injectables Market Share by Application (2017-2028)
    6.4 North America Generic Injectables Market Size by Country
        6.4.1 North America Generic Injectables Market Size by Country (2017-2022)
        6.4.2 North America Generic Injectables Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Generic Injectables Market Size (2017-2028)
    7.2 Europe Generic Injectables Market Size by Type
        7.2.1 Europe Generic Injectables Market Size by Type (2017-2022)
        7.2.2 Europe Generic Injectables Market Size by Type (2023-2028)
        7.2.3 Europe Generic Injectables Market Share by Type (2017-2028)
    7.3 Europe Generic Injectables Market Size by Application
        7.3.1 Europe Generic Injectables Market Size by Application (2017-2022)
        7.3.2 Europe Generic Injectables Market Size by Application (2023-2028)
        7.3.3 Europe Generic Injectables Market Share by Application (2017-2028)
    7.4 Europe Generic Injectables Market Size by Country
        7.4.1 Europe Generic Injectables Market Size by Country (2017-2022)
        7.4.2 Europe Generic Injectables Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Generic Injectables Market Size (2017-2028)
    8.2 Asia-Pacific Generic Injectables Market Size by Type
        8.2.1 Asia-Pacific Generic Injectables Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Generic Injectables Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Generic Injectables Market Share by Type (2017-2028)
    8.3 Asia-Pacific Generic Injectables Market Size by Application
        8.3.1 Asia-Pacific Generic Injectables Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Generic Injectables Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Generic Injectables Market Share by Application (2017-2028)
    8.4 Asia-Pacific Generic Injectables Market Size by Region
        8.4.1 Asia-Pacific Generic Injectables Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Generic Injectables Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Generic Injectables Market Size (2017-2028)
    9.2 Latin America Generic Injectables Market Size by Type
        9.2.1 Latin America Generic Injectables Market Size by Type (2017-2022)
        9.2.2 Latin America Generic Injectables Market Size by Type (2023-2028)
        9.2.3 Latin America Generic Injectables Market Share by Type (2017-2028)
    9.3 Latin America Generic Injectables Market Size by Application
        9.3.1 Latin America Generic Injectables Market Size by Application (2017-2022)
        9.3.2 Latin America Generic Injectables Market Size by Application (2023-2028)
        9.3.3 Latin America Generic Injectables Market Share by Application (2017-2028)
    9.4 Latin America Generic Injectables Market Size by Country
        9.4.1 Latin America Generic Injectables Market Size by Country (2017-2022)
        9.4.2 Latin America Generic Injectables Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Generic Injectables Market Size (2017-2028)
    10.2 Middle East & Africa Generic Injectables Market Size by Type
        10.2.1 Middle East & Africa Generic Injectables Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Generic Injectables Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Generic Injectables Market Share by Type (2017-2028)
    10.3 Middle East & Africa Generic Injectables Market Size by Application
        10.3.1 Middle East & Africa Generic Injectables Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Generic Injectables Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Generic Injectables Market Share by Application (2017-2028)
    10.4 Middle East & Africa Generic Injectables Market Size by Country
        10.4.1 Middle East & Africa Generic Injectables Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Generic Injectables Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Hospira (Pfizer Inc.)
        11.1.1 Hospira (Pfizer Inc.) Company Details
        11.1.2 Hospira (Pfizer Inc.) Business Overview
        11.1.3 Hospira (Pfizer Inc.) Generic Injectables Introduction
        11.1.4 Hospira (Pfizer Inc.) Revenue in Generic Injectables Business (2017-2022)
        11.1.5 Hospira (Pfizer Inc.) Recent Developments
    11.2 Fresenius Kabi
        11.2.1 Fresenius Kabi Company Details
        11.2.2 Fresenius Kabi Business Overview
        11.2.3 Fresenius Kabi Generic Injectables Introduction
        11.2.4 Fresenius Kabi Revenue in Generic Injectables Business (2017-2022)
        11.2.5 Fresenius Kabi Recent Developments
    11.3 Sandoz (Novartis)
        11.3.1 Sandoz (Novartis) Company Details
        11.3.2 Sandoz (Novartis) Business Overview
        11.3.3 Sandoz (Novartis) Generic Injectables Introduction
        11.3.4 Sandoz (Novartis) Revenue in Generic Injectables Business (2017-2022)
        11.3.5 Sandoz (Novartis) Recent Developments
    11.4 Hikma Pharmaceuticals PLC
        11.4.1 Hikma Pharmaceuticals PLC Company Details
        11.4.2 Hikma Pharmaceuticals PLC Business Overview
        11.4.3 Hikma Pharmaceuticals PLC Generic Injectables Introduction
        11.4.4 Hikma Pharmaceuticals PLC Revenue in Generic Injectables Business (2017-2022)
        11.4.5 Hikma Pharmaceuticals PLC Recent Developments
    11.5 Dr. Reddy’s Laboratories Ltd
        11.5.1 Dr. Reddy’s Laboratories Ltd Company Details
        11.5.2 Dr. Reddy’s Laboratories Ltd Business Overview
        11.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectables Introduction
        11.5.4 Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectables Business (2017-2022)
        11.5.5 Dr. Reddy’s Laboratories Ltd Recent Developments
    11.6 Grifols
        11.6.1 Grifols Company Details
        11.6.2 Grifols Business Overview
        11.6.3 Grifols Generic Injectables Introduction
        11.6.4 Grifols Revenue in Generic Injectables Business (2017-2022)
        11.6.5 Grifols Recent Developments
    11.7 Nichi-Iko Group (Sagent)
        11.7.1 Nichi-Iko Group (Sagent) Company Details
        11.7.2 Nichi-Iko Group (Sagent) Business Overview
        11.7.3 Nichi-Iko Group (Sagent) Generic Injectables Introduction
        11.7.4 Nichi-Iko Group (Sagent) Revenue in Generic Injectables Business (2017-2022)
        11.7.5 Nichi-Iko Group (Sagent) Recent Developments
    11.8 Teva Pharmaceutical
        11.8.1 Teva Pharmaceutical Company Details
        11.8.2 Teva Pharmaceutical Business Overview
        11.8.3 Teva Pharmaceutical Generic Injectables Introduction
        11.8.4 Teva Pharmaceutical Revenue in Generic Injectables Business (2017-2022)
        11.8.5 Teva Pharmaceutical Recent Developments
    11.9 Auromedics
        11.9.1 Auromedics Company Details
        11.9.2 Auromedics Business Overview
        11.9.3 Auromedics Generic Injectables Introduction
        11.9.4 Auromedics Revenue in Generic Injectables Business (2017-2022)
        11.9.5 Auromedics Recent Developments
    11.10 Sanofi
        11.10.1 Sanofi Company Details
        11.10.2 Sanofi Business Overview
        11.10.3 Sanofi Generic Injectables Introduction
        11.10.4 Sanofi Revenue in Generic Injectables Business (2017-2022)
        11.10.5 Sanofi Recent Developments
    11.11 Gland Pharma
        11.11.1 Gland Pharma Company Details
        11.11.2 Gland Pharma Business Overview
        11.11.3 Gland Pharma Generic Injectables Introduction
        11.11.4 Gland Pharma Revenue in Generic Injectables Business (2017-2022)
        11.11.5 Gland Pharma Recent Developments
    11.12 Endo International PLC
        11.12.1 Endo International PLC Company Details
        11.12.2 Endo International PLC Business Overview
        11.12.3 Endo International PLC Generic Injectables Introduction
        11.12.4 Endo International PLC Revenue in Generic Injectables Business (2017-2022)
        11.12.5 Endo International PLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Generic Injectables Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Small Molecule
    Table 3. Key Players of Large Molecule
    Table 4. Global Generic Injectables Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Generic Injectables Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Generic Injectables Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Generic Injectables Market Share by Region (2017-2022)
    Table 8. Global Generic Injectables Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Generic Injectables Market Share by Region (2023-2028)
    Table 10. Generic Injectables Market Trends
    Table 11. Generic Injectables Market Drivers
    Table 12. Generic Injectables Market Challenges
    Table 13. Generic Injectables Market Restraints
    Table 14. Global Generic Injectables Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Generic Injectables Revenue Share by Players (2017-2022)
    Table 16. Global Top Generic Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectables as of 2021)
    Table 17. Ranking of Global Top Generic Injectables Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Generic Injectables Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Generic Injectables Product Solution and Service
    Table 21. Date of Enter into Generic Injectables Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Generic Injectables Revenue Market Share by Type (2017-2022)
    Table 25. Global Generic Injectables Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Generic Injectables Revenue Market Share by Type (2023-2028)
    Table 27. Global Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Generic Injectables Revenue Share by Application (2017-2022)
    Table 29. Global Generic Injectables Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Generic Injectables Revenue Share by Application (2023-2028)
    Table 31. North America Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Generic Injectables Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Generic Injectables Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Generic Injectables Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Generic Injectables Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Generic Injectables Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Generic Injectables Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Generic Injectables Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Generic Injectables Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Generic Injectables Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Generic Injectables Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Generic Injectables Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Generic Injectables Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Generic Injectables Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Generic Injectables Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Hospira (Pfizer Inc.) Company Details
    Table 62. Hospira (Pfizer Inc.) Business Overview
    Table 63. Hospira (Pfizer Inc.) Generic Injectables Product
    Table 64. Hospira (Pfizer Inc.) Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 65. Hospira (Pfizer Inc.) Recent Developments
    Table 66. Fresenius Kabi Company Details
    Table 67. Fresenius Kabi Business Overview
    Table 68. Fresenius Kabi Generic Injectables Product
    Table 69. Fresenius Kabi Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 70. Fresenius Kabi Recent Developments
    Table 71. Sandoz (Novartis) Company Details
    Table 72. Sandoz (Novartis) Business Overview
    Table 73. Sandoz (Novartis) Generic Injectables Product
    Table 74. Sandoz (Novartis) Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 75. Sandoz (Novartis) Recent Developments
    Table 76. Hikma Pharmaceuticals PLC Company Details
    Table 77. Hikma Pharmaceuticals PLC Business Overview
    Table 78. Hikma Pharmaceuticals PLC Generic Injectables Product
    Table 79. Hikma Pharmaceuticals PLC Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 80. Hikma Pharmaceuticals PLC Recent Developments
    Table 81. Dr. Reddy’s Laboratories Ltd Company Details
    Table 82. Dr. Reddy’s Laboratories Ltd Business Overview
    Table 83. Dr. Reddy’s Laboratories Ltd Generic Injectables Product
    Table 84. Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 85. Dr. Reddy’s Laboratories Ltd Recent Developments
    Table 86. Grifols Company Details
    Table 87. Grifols Business Overview
    Table 88. Grifols Generic Injectables Product
    Table 89. Grifols Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 90. Grifols Recent Developments
    Table 91. Nichi-Iko Group (Sagent) Company Details
    Table 92. Nichi-Iko Group (Sagent) Business Overview
    Table 93. Nichi-Iko Group (Sagent) Generic Injectables Product
    Table 94. Nichi-Iko Group (Sagent) Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 95. Nichi-Iko Group (Sagent) Recent Developments
    Table 96. Teva Pharmaceutical Company Details
    Table 97. Teva Pharmaceutical Business Overview
    Table 98. Teva Pharmaceutical Generic Injectables Product
    Table 99. Teva Pharmaceutical Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 100. Teva Pharmaceutical Recent Developments
    Table 101. Auromedics Company Details
    Table 102. Auromedics Business Overview
    Table 103. Auromedics Generic Injectables Product
    Table 104. Auromedics Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 105. Auromedics Recent Developments
    Table 106. Sanofi Company Details
    Table 107. Sanofi Business Overview
    Table 108. Sanofi Generic Injectables Product
    Table 109. Sanofi Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 110. Sanofi Recent Developments
    Table 111. Gland Pharma Company Details
    Table 112. Gland Pharma Business Overview
    Table 113. Gland Pharma Generic Injectables Product
    Table 114. Gland Pharma Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 115. Gland Pharma Recent Developments
    Table 116. Endo International PLC Company Details
    Table 117. Endo International PLC Business Overview
    Table 118. Endo International PLC Generic Injectables Product
    Table 119. Endo International PLC Revenue in Generic Injectables Business (2017-2022) & (US$ Million)
    Table 120. Endo International PLC Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Generic Injectables Market Share by Type: 2021 VS 2028
    Figure 2. Small Molecule Features
    Figure 3. Large Molecule Features
    Figure 4. Global Generic Injectables Market Share by Application: 2021 VS 2028
    Figure 5. Oncology Case Studies
    Figure 6. Anesthesia Case Studies
    Figure 7. Anti-Infectives Case Studies
    Figure 8. Parenteral Nutrition Case Studies
    Figure 9. Cardiovascular Diseases Case Studies
    Figure 10. Generic Injectables Report Years Considered
    Figure 11. Global Generic Injectables Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Generic Injectables Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Generic Injectables Market Share by Region: 2021 VS 2028
    Figure 14. Global Generic Injectables Market Share by Players in 2021
    Figure 15. Global Top Generic Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectables as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Generic Injectables Revenue in 2021
    Figure 17. North America Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Generic Injectables Market Size Market Share by Type (2017-2028)
    Figure 19. North America Generic Injectables Market Size Market Share by Application (2017-2028)
    Figure 20. North America Generic Injectables Market Size Share by Country (2017-2028)
    Figure 21. United States Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Generic Injectables Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Generic Injectables Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Generic Injectables Market Size Share by Country (2017-2028)
    Figure 27. Germany Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Generic Injectables Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Generic Injectables Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Generic Injectables Market Size Share by Region (2017-2028)
    Figure 37. China Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Generic Injectables Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Generic Injectables Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Generic Injectables Market Size Share by Country (2017-2028)
    Figure 47. Mexico Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Generic Injectables Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Generic Injectables Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Generic Injectables Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Generic Injectables Market Size Share by Country (2017-2028)
    Figure 53. Turkey Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Generic Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Hospira (Pfizer Inc.) Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 57. Fresenius Kabi Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 58. Sandoz (Novartis) Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 59. Hikma Pharmaceuticals PLC Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 60. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 61. Grifols Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 62. Nichi-Iko Group (Sagent) Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 63. Teva Pharmaceutical Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 64. Auromedics Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 65. Sanofi Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 66. Gland Pharma Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 67. Endo International PLC Revenue Growth Rate in Generic Injectables Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Frequently Asked Questions
Generic Injectables report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Generic Injectables report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Generic Injectables report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports